David Seaburg
Chief Executive Officer en STELLA DIAGNOSTICS INC. .
Fortuna: 7 775 $ al 31/03/2024
Perfil
David Seaburg is currently the Chief Executive Officer & Director at Stella Diagnostics, Inc. and the Director at Stella Diagnostics LLC.
Previously, he worked as the Managing Director & Head-Sales Trading at Cowen & Co. LLC from 1998 to 2020.
He also served as the Director at RegenETP, Inc. from 2021 to 2023.
Mr. Seaburg obtained his undergraduate degree from Northeastern University in 1993.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
REGENETP INC.
0.97% | 20/03/2023 | 71 272 ( 0.97% ) | 7 127 $ | 31/03/2024 |
STELLA DIAGNOSTICS INC.
0.10% | 30/06/2022 | 9 000 ( 0.10% ) | 648 $ | 31/03/2024 |
Cargos activos de David Seaburg
Empresas | Cargo | Inicio |
---|---|---|
STELLA DIAGNOSTICS INC. | Chief Executive Officer | 22/04/2022 |
Stella Diagnostics LLC
Stella Diagnostics LLC Medical SpecialtiesHealth Technology Stella Diagnostics LLC engages in the provision of molecular diagnostic services. Its StellaDX’s mass spec proteomic assays offers physicians insight into the molecular properties of patients’ tissue to determine if the disease is stable, progressing or turning cancerous. The company is headquartered in New York, NY. | Director/Board Member | 25/02/2021 |
Antiguos cargos conocidos de David Seaburg.
Empresas | Cargo | Fin |
---|---|---|
REGENETP, INC. | Chief Executive Officer | 01/09/2021 |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Sales & Marketing | 01/05/2020 |
Formación de David Seaburg.
Northeastern University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
REGENETP, INC. | Health Technology |
STELLA DIAGNOSTICS INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Stella Diagnostics LLC
Stella Diagnostics LLC Medical SpecialtiesHealth Technology Stella Diagnostics LLC engages in the provision of molecular diagnostic services. Its StellaDX’s mass spec proteomic assays offers physicians insight into the molecular properties of patients’ tissue to determine if the disease is stable, progressing or turning cancerous. The company is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- David Seaburg